VIRAGEN

viragen-logo

Viragen, together with its subsidiaries, engages in the research, development, manufacture, and commercialization of therapeutic proteins for the treatment of cancers and viral diseases in humans. Its product and product candidate portfolio includes Multiferon, a human alpha interferon product that comprise multiple subtype alpha interferons for the treatment of various infectious diseases and cancers; VG101 a therapeutic humanized monoclonal antibody targeting the treatment of malignant melanom... a; and VG102 a therapeutic humanized antibody designed for the treatment of various solid tumors. The company also develops Avian Transgenics technology for production of human therapeutic proteins and antibodies. It operates in the United States, Scotland, and Sweden. The company was founded in 1979 and is headquartered in Plantation, Florida.

#SimilarOrganizations #Financial #More

VIRAGEN

Industry:
Biotechnology Manufacturing Therapeutics

Founded:
1979-01-01

Address:
Fort Lauderdale, Florida, United States

Country:
United States

Status:
Active

Total Funding:
9.43 M USD


Similar Organizations

anika-therapeutics-logo

Anika Therapeutics

Anika Therapeutics, Inc. develops, manufactures, and commercializes therapeutic products for tissue protection, healing, and repair. Its

Investors List

rab-capital_image

RAB Capital

RAB Capital investment in Venture Round - Viragen

pef-advisors_image

PEF Advisors

PEF Advisors investment in Venture Round - Viragen

More informations about "Viragen" on Search Engine